Shingles vaccine booster study for adults 50 and older
This study tests a live-attenuated shingles vaccine as a booster for people who have already had a recombinant shingles vaccine. It aims to see if the booster is safe and helps maintain protection against shingles.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You have already received a recombinant shingles vaccine (like Shingrix).
- You have not had shingles before.
- You have not received any shingles or chickenpox vaccine before.
- You do not have a weakened immune system (e.g., from cancer, HIV, or immunosuppressive drugs).
- You are not pregnant or planning to become pregnant within 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a live shingles vaccine to see how well it works and how safe it is. It may help prevent shingles in adults aged 40 and up.
This study tests a new vaccine to protect against shingles (herpes zoster), a painful skin infection that can affect people as they age. You would receive the vaccine and be monitored to see if it's safe and how your body responds.
This trial tests a new shingles vaccine to see how well it prevents shingles in adults aged 40 and older. It aims to help those who have not had shingles recently or been vaccinated against it before.
This study tests a new shingles vaccine to make sure each batch works the same way. If you are 40 or older and have never had shingles or the shingles vaccine, you may qualify.
This study tests an experimental shingles vaccine in adults aged 40 and older. It aims to see if the vaccine is safe and helps your body build immunity against shingles.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
Hear when a new Herpse Zoster trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.